AGT researchers net $4.4m NIH grant
Thursday, 03 July, 2003
Researchers associated with Victorian-based AGT Biosciences have landed a $AUD4.4 million grant from the US National Institutes of Health to fund its human gene discovery research.
The grant, awarded over a period of five years, will be shared between Prof Ahmed Kissebah of the Medical College of Wisconsin, Dr John Blangero of AGT and the Texas-based Southwest Foundation for Biomedical Research, and the AGT team at Deakin University, Geelong.
Prof Greg Collier, AGT's CEO and managing director, said in a statement that the grant was a strong affirmation of AGT's approach to solving problems of complex human diseases.
He said the grant would support a trilateral collaboration between Kissebah (population genetics), Blangero's team (statistical genomics) and AGT's eXpress technology platform.
Epilepsy disease model treated in a laboratory dish
A research team has used an epilepsy-like disease model in a laboratory dish to demonstrate that...
Newborns have elevated levels of an Alzheimer's biomarker
What do the brains of newborns and patients with Alzheimer's disease have in common? Both...
Cannabis use may double risk of cardiovascular disease death
Cannabis users have a 29% higher risk of acute coronary syndrome, a 20% higher risk of stroke,...
